Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of seletracetam in adults with refractory partial-onset seizures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• Seletracetam (Seletracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsies, Partial | Phase 2, Phase 3 | Status: WITHDRAWN